Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 307-585-4 | CAS number: 97660-72-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
A limit dose acute oral toxicity study in the rat is available for this substance
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May 10, 2016 to September 02, 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- up-and-down procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Animal Breeding Facility, Jai Research Foundation
- Females (if applicable) nulliparous and non-pregnant: Yes
- Age at study initiation: 10 to 12 weeks
- Weight at study initiation: Minimum: 186.3g, Maximum: 199.8g
- Fasting period before study: Overnight prior to dosing and 3 hours post dosing
- Housing: Rats were housed individually in standard polypropylene solid bottom cages which conform to the size recommendations in the most recent Guide for the Care and Use of Laboratory Animals (Natl. Res. Council, 2011). These cages have stainless steel top grills with steam sterilized corn cob bedding material and facilities for pelleted feed and drinking water (polypropylene bottle fitted with sipper tube). Rack units were rotated once in a week. Rats were provided with a wooden block in each cage.
- Diet (e.g. ad libitum): ad libitum; Teklad Certified Global High fiber rat pellet feed manufactured by Envigo, USA
- Water (e.g. ad libitum):ad libitum - polypropylene water bottle with a stainless steel nozzle
- Acclimation period: 8-20days
- Identification: Each rat was uniquely numbered on the tail using a tattoo machine. Appropriate labels were attached to the cages indicating the study number, test item code and sex, dose, study code, cage number and animal number.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-23
- Humidity (%): 49-66
- Air changes (per hr): 17
- Photoperiod (hrs dark / hrs light): 12 (06:00 - 18:00)
IN-LIFE DATES: From: To: 25/05/2016 - 06/6/2016 - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/ml
- Amount of vehicle (if gavage): Not indicated
- Justification for choice of vehicle: test material insoluble in aqueous vehicles, and formed an acceptable suspension in corn oil
- Lot/batch no. (if required): Sigma life science; Batch Nº MKBS6944V
MAXIMUM DOSE VOLUME APPLIED: 10 mL/Kg bw
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 females
- Control animals:
- no
- Details on study design:
- Study Design:
This study was conducted as a limit study with the dose level of 2000 mg/kg body weight. The first rat was given a single dose of 2000 mg 1-Phenyl-3-methyl-4-(p-dodecylphenylazo)-5-pyrazolone/kg body weight. No mortality was observed at this dose level up to 48 h post dosing. Therefore, rat N° 2, 3, 4 and 5 were treated with the same dose level of 2000 mg 1-Phenyl-3-methyl-4-(p-dodecylphenylazo)-5-pyrazolone/kg body weight, one at a time, separated by minimum 48 h intervals. As no mortality was observed at the dose level of 2000 mg 1-Phenyl-3-methyl-4-(p-dodecylphenylazo)-5-pyrazolone/kg body weight, the end point was achieved and further testing was not required.
Observations
The rats were observed for signs of toxicity and mortality at 0.5, 1, 2, 3, 4 and 5-6 hours post-administration on the day of dosing. Subsequently, the rats were observed twice a day for morbidity and mortality for a period of 14 days following oral dosing. The clinical signs were recorded once a day. Individual body weight was recorded prior to dosing on day 1, and on days 8 and 15.
Necropsy
At study termination, all the rats were humanely euthanised by carbon dioxide asphyxiation. All rats on the study were subject to a gross pathological examination consisting of an external examination and opening of abdominal and thoracic cavities. The stomach of each rat was opened, the contents rinsed/removed, and the mucosal surface was examined for signs of irritation, erosions, ulcers or any other findings. Gross macroscopic changes, if any, were recorded. - Statistics:
- The LD50 was calculated using the Dixon’s maximum likelihood method using software (AOT 425 StatPgm)
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed in the study
- Clinical signs:
- other: No clinical signs were observed during the study
- Gross pathology:
- External examination of the terminally sacrificed rats did not reveal any pathological lesions in any of the treated animals.
Internal: Visceral examination of the terminally sacrificed rats did not reveal any pathological lesions in any of the treated animals. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- THe LD50 of 1-Phenyl-3-methyl-4-(p-dodecylphenylazo)-5-pyrazolone/kg body weight in female Wistar rats was determined to be >2000 mg/kg bw.
- Executive summary:
An acute oral toxicity study(Up-and-Down Procedure) was conducted using five female Wistar rats given a single oral dose of1-Phenyl-3-methyl-4-(p-dodecylphenylazo)-5-pyrazolonemixed in corn oil. A Limit Test was conducted with 2000 mg/kg body weight. The first rat survived; hence the four additional female Wistar rats each received a single dose of 2000 mg/kg body weight according to the Up-and-Down Procedure.
No sign of toxicity was observed in the rats treated with the1-Phenyl-3-methyl-4-(p-dodecylphenylazo)-5-pyrazoloneat 2000 mg/Kg body weight.
All rats were active and healthy during the study. All the rats gained body weight by the end of the study.
External and visceral examination of terminally sacrificed animals did not reveal any pathological lesions in any of the treated animals.
The acute oral LD50of the 1-Phenyl-3-methyl-4-(p-dodecylphenylazo)-5-pyrazolone was found to be greater than 2000 mg/kg body weight in female Wistar rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- Good
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The acute oral toxicity of 1-Phenyl-3-methyl-4-(p-dodecylphenylazo)-5-pyrazolone was determined to be >2000 mg/kg bw in female Wistar rats.
Justification for classification or non-classification
The LD50 is >2000 mg/kg bw, therefore the CLP and GHS criteria for classification for acute toxicity are not met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.